DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/wxk623/neuromyelitis) has announced the addition of the "Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2013" report to their offering.
'Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Neuromyelitis Optica (Devic's Syndrome), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neuromyelitis Optica (Devic's Syndrome).
Scope
- A snapshot of the global therapeutic scenario for Neuromyelitis Optica (Devic's Syndrome).
- A review of the Neuromyelitis Optica (Devic's Syndrome) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Neuromyelitis Optica (Devic's Syndrome) pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Key Topics Covered:
Introduction
Neuromyelitis Optica (Devic's Syndrome) Overview
Therapeutics Development
Clinical Stage Products
Early Stage Products
Neuromyelitis Optica (Devic's Syndrome) - Therapeutics Assessment
Drug Profiles
eculizumab - Drug Profile
NPB-01 - Drug Profile
NU-211-01 + NU-215-02 - Drug Profile
conestat alfa - Drug Profile
HL-161 - Drug Profile
ALN-CC5 - Drug Profile
Neuromyelitis Optica (Devic's Syndrome) - Recent Pipeline Updates
Neuromyelitis Optica (Devic's Syndrome) - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Companies Mentioned
ViroPharma Incorporated
Alexion Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
HanAll Biopharma Co., Ltd.
Shenzhen Beike Biotechnology Co., Ltd.
Nihon Pharmaceutical Industry Co., Ltd.
For more information visit http://www.researchandmarkets.com/research/wxk623/neuromyelitis
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
